Found: 2
Select item for more details and to access through your institution.
A randomized single and multiple ascending dose study in healthy volunteers of LTI‐291, a centrally penetrant glucocerebrosidase activator.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3561, doi. 10.1111/bcp.14772
- By:
- Publication type:
- Article
A Phase 1B Trial in GBA1‐Associated Parkinson's Disease of BIA‐28‐6156, a Glucocerebrosidase Activator.
- Published in:
- Movement Disorders, 2023, v. 38, n. 7, p. 1197, doi. 10.1002/mds.29346
- By:
- Publication type:
- Article